Thalidomide-5'-O-PEG2-C2-azide CAS 2640388-57-2
| CAS No. | 2640388-57-2 |
| Molecular Formula | C19H21N5O7 |
| Molecular Weight | 431.40 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
CATO manufactures Thalidomide-5'-O-PEG2-C2-azide under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
CATO supplies Thalidomide-5'-O-PEG2-C2-azide (CAS 2640388-57-2), a certified reference material (molecular formula C19H21N5O7, MW 431.40 g/mol) for analytical method development and quality control.
The molecular framework of Thalidomide-5'-O-PEG2-C2-azide (C19H21N5O7) is characterized by a flavonoid core, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
Physical & Chemical Properties
| Molecular Formula | C19H21N5O7 |
| Molecular Weight | 431.40 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 12.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2002 |
| Nitrogen Atoms | 5 |
Related Thalidomide Standards
- Thalidomide-O-amido-C6-NH2 (CAS 1950635-13-8)
- Thalidomide-O-amido-C4-N3 (CAS 2098488-36-7)
- Thalidomide-O-PEG2-C2-Cl (CAS 2349355-96-8)
- Thalidomide-O-amido-PEG-C2-NH2 (CAS 2022182-59-6)
- Thalidomide-O-PEG3-propargyl (CAS 2098799-76-7)
- Thalidomide-NH-C4-NH-Boc (CAS 2093388-52-2)
- Thalidomide-O-acetamido-C5-acid (CAS 2354352-06-8)
- Thalidomide-O-amido-C3-COOH (CAS 2308035-51-8)
Recommended Standards
- (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)acetic acid (CAS 1992961-04-2)
- Varenicline Carbamoyl-B-D-Glucuronide (CAS 535920-98-0)
- (2s)-2-({[(9h-fluoren-9-yl)methoxy]carbonyl}amino)-2-[3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl]acetic acid (CAS 914082-67-0)
- Deferasirox Impurity 18 (CAS 1395346-29-8)
- Taltirelin Impurity 1 (CAS 103300-77-2)
- 2-(4-Butoxyphenyl)-8-chloroquinoline-4-carboxylic acid (CAS 863185-06-2)
- 1-[(4-Bromo-2-fluorophenyl)methyl]-4-nitro-1h-pyrazole (CAS 1240568-53-9)
- (S)-tert-Butyl 2-(tert-butyl)piperazine-1-carboxylate hydrochloride (CAS 1381959-73-4)
- 4-[(4-bromophenyl)sulfanyl]aniline hydrochloride (CAS 156813-62-6)
- 4,4,5,5-Tetramethyl-2-[3-(triphenylen-2-yl)phenyl]-1,3,2-dioxaborolane (CAS 1115639-92-3)
- Ethyl 3-(2-chloroacetamido)-5-methoxy-1H-indole-2-carboxylate (CAS 1134334-63-6)
- 2-Chloro-5-((methylsulfonyl)methyl)thiazole (CAS 866039-50-1)
- 2-Oxo-2-(10H-phenothiazin-10-yl)ethyl 2-(furan-2-carboxamido)benzoate (CAS 474386-43-1)
- D-[Val]10-Semaglutide (CAS CATO-CPTD788630)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com